CSPC Innovation Pharmaceutical Balance Sheet Health
Financial Health criteria checks 6/6
CSPC Innovation Pharmaceutical has a total shareholder equity of CN¥5.5B and total debt of CN¥0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are CN¥6.5B and CN¥989.3M respectively. CSPC Innovation Pharmaceutical's EBIT is CN¥699.5M making its interest coverage ratio -11.7. It has cash and short-term investments of CN¥2.7B.
Key information
0%
Debt to equity ratio
CN¥0
Debt
| Interest coverage ratio | -11.7x |
| Cash | CN¥2.69b |
| Equity | CN¥5.48b |
| Total liabilities | CN¥989.34m |
| Total assets | CN¥6.47b |
Recent financial health updates
No updates
Recent updates
Estimating The Fair Value Of CSPC Innovation Pharmaceutical Co., Ltd. (SZSE:300765)
Aug 16
CSPC Innovation Pharmaceutical Co., Ltd.'s (SZSE:300765) 27% Share Price Plunge Could Signal Some Risk
Jul 04CSPC Innovation Pharmaceutical's (SZSE:300765) Weak Earnings May Only Reveal A Part Of The Whole Picture
Apr 29CSPC Innovation Pharmaceutical (SZSE:300765) Will Pay A Larger Dividend Than Last Year At CN¥0.32
Apr 25CSPC Innovation Pharmaceutical Co., Ltd.'s (SZSE:300765) P/E Still Appears To Be Reasonable
Apr 24Financial Position Analysis
Short Term Liabilities: 300765's short term assets (CN¥3.6B) exceed its short term liabilities (CN¥925.5M).
Long Term Liabilities: 300765's short term assets (CN¥3.6B) exceed its long term liabilities (CN¥63.8M).
Debt to Equity History and Analysis
Debt Level: 300765 is debt free.
Reducing Debt: 300765 has no debt compared to 5 years ago when its debt to equity ratio was 3.2%.
Debt Coverage: 300765 has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: 300765 has no debt, therefore coverage of interest payments is not a concern.